» Articles » PMID: 35185845

Characteristics of the Gut Microbiome and Its Relationship With Peripheral CD4 T Cell Subpopulations and Cytokines in Rheumatoid Arthritis

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2022 Feb 21
PMID 35185845
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated the association between intestinal microbiota abundance and diversity and cluster of differentiation (CD)4 T cell subpopulations, cytokine levels, and disease activity in rheumatoid arthritis RA. A total of 108 rheumatoid arthritis (RA) patients and 99 healthy control (HC) subjects were recruited. PICRUSt2 was used for functional metagenomic predictions. Absolute counts of peripheral CD4 T cell subpopulations and cytokine levels were detected by flow cytometry and with a cytokine bead array, respectively. Correlations were analyzed with the Spearman rank correlation test. The results showed that the diversity of intestinal microbiota was decreased in RA patients compared to HCs. At the phylum level, the abundance of Firmicutes, Fusobacteriota, and Bacteroidota was decreased while that of Actinobacteria and Proteobacteria was increased and at the genus level, the abundance of , , and was increased while that of and was decreased in RA patients compared to HC subjects. The linear discriminant analysis effect size indicated that was the most significant genus in RA. The most highly enriched Kyoto Encyclopedia of Genes and Genomes pathway in RA patients was amino acid metabolism. The relative abundance of , , and was positively correlated with CD4 T cell counts and cytokine levels; and the relative numbers of regulatory T cells (Tregs) and T helper (Th17)/Treg ratio were negatively correlated with disease activity in RA. These results suggest that dysbiosis of certain bacterial lineages and alterations in gut microbiota metabolism lead to changes in the host immune profile that contribute to RA pathogenesis.

Citing Articles

A Case Series Report on the Effect of Tofacitinib on Joint Inflammation and Gut Microbiota Composition in Psoriatic Arthritis Patients Naive to Biologic Agents.

Picchianti Diamanti A, Panebianco C, Di Gioia V, Bellofatto I, Salemi S, Di Rosa R Microorganisms. 2025; 12(12.

PMID: 39770590 PMC: 11676042. DOI: 10.3390/microorganisms12122387.


Gut microbiota mediated T cells regulation and autoimmune diseases.

Bhutta N, Xu X, Jian C, Wang Y, Liu Y, Sun J Front Microbiol. 2025; 15:1477187.

PMID: 39749132 PMC: 11694513. DOI: 10.3389/fmicb.2024.1477187.


Correlation analysis of the impact of juvenile on gut microbiota and transcriptome in mice.

Deng X, Li S, Wu Y, Yao J, Hou W, Zheng J Microbiol Spectr. 2024; 13(2):e0155024.

PMID: 39727670 PMC: 11792474. DOI: 10.1128/spectrum.01550-24.


Investigating the causal impact of gut microbiota on arthritis via inflammatory proteins using mendelian randomization.

Pan B, Guo Q, Cai J, Chen L, Zhao Z, Shen P Sci Rep. 2024; 14(1):27433.

PMID: 39521893 PMC: 11550855. DOI: 10.1038/s41598-024-79336-9.


Causal Relationship Between Sjögren's Syndrome and Gut Microbiota: A Two-Sample Mendelian Randomization Study.

Wang X, Liu M, Xia W Biomedicines. 2024; 12(10).

PMID: 39457690 PMC: 11505323. DOI: 10.3390/biomedicines12102378.


References
1.
Zhao C, Chu Y, Liang Z, Zhang B, Wang X, Jing X . Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17/Treg cells in refractory SLE patients. BMC Immunol. 2019; 20(1):32. PMC: 6727508. DOI: 10.1186/s12865-019-0305-0. View

2.
Jeong Y, Kim J, You H, Park S, Lee J, Ju J . Gut Microbial Composition and Function Are Altered in Patients with Early Rheumatoid Arthritis. J Clin Med. 2019; 8(5). PMC: 6572219. DOI: 10.3390/jcm8050693. View

3.
Zhang K, Ip C, Chung S, Lei K, Zhang Y, Liu L . Drug-resistance in rheumatoid arthritis: the role of p53 gene mutations, ABC family transporters and personal factors. Curr Opin Pharmacol. 2020; 54:59-71. DOI: 10.1016/j.coph.2020.08.002. View

4.
Maeda Y, Takeda K . Host-microbiota interactions in rheumatoid arthritis. Exp Mol Med. 2019; 51(12):1-6. PMC: 6906371. DOI: 10.1038/s12276-019-0283-6. View

5.
Douglas G, Maffei V, Zaneveld J, Yurgel S, Brown J, Taylor C . PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020; 38(6):685-688. PMC: 7365738. DOI: 10.1038/s41587-020-0548-6. View